Peter Greenleaf, Director at Pelthos Therapeutics Inc. (PTHS), sold 797 shares at $26.00 ($21K) on 2026-07-02, disclosed to the SEC on 2026-07-07.
Scheduled sale ($21k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.00 | 712 | $19K | 88.9% |
| 2 | $27.27 | 85 | $2K | 11.1% |
| Total | $26.13 avg | 797 | $21K | 100% |
| Filing → |
| AUPH | SELL | 2024-03-07 | $1.4M | — | Filing → |
| AUPH | SELL | 2024-02-22 | $580K | — | Filing → |
| AUPH | SELL | 2022-03-04 | $218K | — | Filing → |